N-(5-(2,3-dihidrobenzo[b][1,4]dioxina-6-carboxamido)-2-fluorofenil)-2-((4-etilpiperazin-1-il)metil)quinolin-6- carboxamida deuterada

Un compuesto, o una de sus sales o solvatos farmacéuticamente aceptables, seleccionado de **(Ver fórmula)** y The present invention relates to N-(5-(2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamido)-2-fluorophenyl)-2-((4-ethylpiperazin-1-yl)methyl)quinoline-6-carboxamide, or a pharmaceutically acceptab...

Full description

Saved in:
Bibliographic Details
Main Authors TUCKER, Michael J, PASQUA, A. Elisa, CHEESEMAN, Matthew D, JONES, Keith
Format Patent
LanguageSpanish
Published 25.04.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Un compuesto, o una de sus sales o solvatos farmacéuticamente aceptables, seleccionado de **(Ver fórmula)** y The present invention relates to N-(5-(2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamido)-2-fluorophenyl)-2-((4-ethylpiperazin-1-yl)methyl)quinoline-6-carboxamide, or a pharmaceutically acceptable salt or solvate thereof, wherein at least one hydrogen atom has been substituted with a deuterium atom. Other aspects include pharmaceutical compositions comprising said compounds and medical uses and methods of treatment using said compounds.
Bibliography:Application Number: ES20170783566T